Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS
Clinical trial NCT02231008 · COMPLETED
Trial details
- NCT number
- NCT02231008
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2018-11-19
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.